Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-11

Clinical Trial Update: MagniXene MRI Use in Patients With Asthma and COPD to Assess Regional Lung Function by Delineating Ventilation Defects [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating MagniXene MRI to assess regional lung function by delineating ventilation defects in patients with asthma and chronic obstructive pulmo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MagniXene

Snippet

Sponsor: Xemed LLC | Conditions: Asthma, COPD | Phase 2 | Status: COMPLETED